← Eichor
Condition: Eosinophilia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Eosinophilia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT06959719Prospective Registry of EoSinophilic esOphagitis
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06443346Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Phase N/A · 1 location(s) · Children's Hospital of Philadelphia · NCT06389994A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in
NA · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07027826Eosinophilic Gastrointestinal Disorders Registry
Phase N/A · 1 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT05199532Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06381219A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Phase 3 · 11 location(s) · Regeneron Pharmaceuticals · NCT07112378A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Phase 1 · 1 location(s) · Jemincare · NCT06740019A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Phase N/A · 11 location(s) · University Hospital, Lille · NCT04330118Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
Phase N/A · 1 location(s) · University Hospital, Lille · NCT04018118European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Phase N/A · 3 location(s) · Matthias Griese · NCT02852928Indiana University Gastrointestinal Motility Diagnosis Registry
Phase N/A · 1 location(s) · Indiana University · NCT04506593Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biolog
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06477653A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00091871Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Phase 3 · 27 location(s) · Dr. Falk Pharma GmbH · NCT06596252Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (E
Phase 4 · 1 location(s) · University of California, San Diego · NCT06665971Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
Phase 3 · 1 location(s) · Craig A. Friesen, MD · NCT02484248Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial
NA · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07120867PRospective Registry of Esophageal Motility
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT07506746Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT06705387National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05219903Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
NA · 1 location(s) · Kate Farms Inc · NCT07234825Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Phase 2 · 4 location(s) · William Shomali · NCT03801434Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · 160 location(s) · AstraZeneca · NCT06750289Study of Gastric Motility in Eosinophilic Gastritis
Phase N/A · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05229432Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
NA · 1 location(s) · Shaare Zedek Medical Center · NCT05180578
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.